Solitary fibrous tumor (SFT) of the liver is a rare entity and its presentation is usually delayed till they grow to a substantial size. Clinico-radiological features are non-specific, contributing to increase in the diagnostic dilemma. Definitive diagnosis of SFT is usually made based on the histological features and immunohistochemistry data of the resected specimen. In this case report, we describe the case of an elderly male who presented with a large mass in the left lobe of the liver with normal level of tumor markers and atypical radiological findings. The patient successfully underwent resection of the tumor and the diagnosis was confirmed on histopathology. (Ann Hepatobiliary Pancreat Surg 2018;22:156-158)
INTRODUCTION
Solitary fibrous tumor (SFT) of the liver is a rare mesenchymal tumor. It is usually found in pleura and pelvis 1 but can also occur in other unusual sites such as central nervous system, orbit, retroperitoneum, maxillary sinus, pancreas, and kidneys. [2] [3] [4] [5] Histologically, they are characterized by proliferation of spindle cells, and immunohistochemically they are positive for CD34. 6 Usually, SFTs are benign in nature, but 10-20% of them are reported to be malignant with a tendency to metastasize. 7 Nonspecific clinico-radiological features of these tumors often delay the diagnosis as precise diagnosis can only be made based on histopathological data.
Surgery is the best therapeutic modality with outcomes dependant on resectability. 
DISCUSSION
SFT primarily arising from the liver is an unusual occurrence, which makes diagnosis and treatment of this rare tumor challenging. SFT arising from the liver was first reported by Nevius and Friedman in 1959. 9 These tumors are usually seen in an elderly population with a female preponderance. 10 Clinical presentation of these tumors is usually non-specific and most of the patients are asymptomatic initially until the tumor attains a large size and presents with symptoms due to mass effect or cholestasis. 11 The radiological findings of SFT are non-specific and it is hypothesized that other space-occupying lesions in the liver like hepatocellular carcinoma, sarcoma, and inflammatory pseudotumor can also have similar radiological features. 12 Similarly, benign tumors cannot be reliably differentiated from malignant tumors due to overlapping features. On ultrasound, SFT typically appears hypoechoic but occasionally they are heterogeneous, likely due to areas of myxoid degeneration. 13 On CT scan, they appear as a well-defined encapsulated mass with heterogeneous enhancement. On and ＞4 mitoses/10 high porwer field. 19 Complete surgical excision is the treatment of choice for hepatic SFT. If margin-negative resection is achieved, no further treatment is needed. 19 For inoperable or incompletely resected tumors, liver-directed therapies in the form of trans-arterial chemoembolization may be offered, but there exists no robust evidence to support this modality. 16 Until date, there exist no studies which describe long-term outcomes of these tumors. Therefore, follow up is advised as some of the patients with benign tumors on initial histological examination developed distant metastasis later. 19 In conclusion, SFT arising from the liver is a rare entity. It should be considered as a differential diagnosis in liver lesions with atypical radiological findings.
Complete surgical excision is advised for definitive diagnosis and to predict aggressiveness based on histological features. Long-term follow-up in patients with SFT is essential as the tumor biology remains unknown. Therefore, follow up is advised as some of the patients with benign tumors on initial histological examination developed distant metastasis later.
